解开CD8+ T细胞的共免疫:从现代实验工具对抗原识别的直接途径的洞察
Joel S Freibaum1, Riley P Leathem1, William Braaton1
1Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.
新的研究阐明了CD8+ T细胞如何通过直接的异构抗原识别来识别外来抗原 (非免疫性). 这种依赖的途径对于理解移植排斥和耐受性至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 移植免疫学 移植免疫学
- T细胞生物学T细胞生物学
背景情况:
- 类免疫性涉及T细胞对外来抗原的反应,历史上通过直接的异性抗原识别来建模.
- CD8+ T 细胞识别了由主要基因相容性复合体 (MHC) 分子呈现的全基性.
研究的目的:
- 通过使用现代实验技术,研究CD8+ T细胞直接异构抗原识别的机制.
- 阐明非免疫性中CD8+T细胞反应的依赖性和MHC限制.
主要方法:
- 利用MHC I类四度体来分析小鼠和人类的CD8+T细胞反应.
- 研究了一种肝移植耐受性模型,以评估依赖的非免疫反应.
- 雇佣工程人工抗原呈现细胞来检查人类的全活性T细胞.
主要成果:
- 证实MHC I类非免疫CD8+T细胞反应是依赖的.
- 鉴定了H-Ld QL9的全源表位,并证明了分辨T细胞.
- 显示人类对HLA A抗原的全活性CD8+T细胞是MHC受限的,揭示了一个公共的HLA A2反应.
结论:
- 现代实验工具提供了详细的证据,证明了CD8+ T细胞识别机制与免疫.
- 这些发现为开发选择性向全活性CD8+T细胞的策略提供了框架.
- 了解直接的异构抗原识别是改善移植结果的关键.
更多相关视频
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
08:25Unraveling Key Players of Humoral Immunity: Advanced and Optimized Lymphocyte Isolation Protocol from Murine Peyer's Patches
Published on: November 21, 2018
相关概念视频
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Restarting Stalled Replication Forks
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
